Mrna-Based Vaccines Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension
Available Strengths: 30 µg and 100 µg
Reference Brands: Comirnaty, Spikevax(US)
Category:
Vaccines
mRNA vaccines work by delivering genetic instructions that enable cells to produce the coronavirus spike protein, triggering an immune response. They provide rapid, effective protection against COVID-19, reduce severe illness, support herd immunity, and are safe for most populations, supporting global vaccination efforts to control the pandemic.
mRNA-based Vaccines is available in Injectable suspension
and strengths such as 30 µg and 100 µg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, mRNA-based Vaccines is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
mRNA-based Vaccines can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
mRNA-based vaccines, such as Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical trials, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing processes. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees safe, effective COVID-19 protection globally, supporting public health efforts.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing